E2F-1 as an anticancer drug target

by Joseph R. Bertino, Debabrata Banerjee
Published 2011-12-01

Evaluation of Dose-Intense Ifosfamide, with and Without Edatrexate, in Adults with Sarcoma

by Ephraim S. Casper, Gary M. Schwartz, Denis Leung, Alison Sugarman, Joseph R. Bertino
Published 1999-01-01

NAD- and NADPH-Contributing Enzymes as Therapeutic Targets in Cancer: An Overview

by Alvinsyah Adhityo Pramono, Gulam M. Rather, Herry Herman, Keri Lestari, Joseph R. Bertino
Published 2020-02-01

A Novel Antibody-Toxin Conjugate to Treat Mantle Cell Lymphoma

by Gulam M. Rather, Siang-Yo Lin, Hongxia Lin, Zoltan Szekely, Joseph R. Bertino
Published 2019-04-01

Anti-Tumor Effects of a Penetratin Peptide Targeting Transcription of E2F-1, 2 and 3a Is Enhanced When Used in Combination with Pemetrexed or Cisplatin

by Gulam Mohmad Rather, Michael Anyanwu, Tamara Minko, Olga Garbuzenko, Zoltan Szekely, Joseph R. Bertino
Published 2021-02-01

Translational Modulation of Proteins Expressed from Bicistronic Vectors

by Prasun J. Mishra, Lata G. Menon, Pravin J. Mishra, Philipp Mayer-Kuckuk, Joseph R. Bertino, Debabrata Banerjee
Published 2009-11-01

MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism.

by Prasun J Mishra, Bo Song, Pravin J Mishra, Yuan Wang, Rita Humeniuk, Debabrata Banerjee, Glenn Merlino, Jingfang Ju, Joseph R Bertino
Published 2009-12-01

Molecular Imaging Reveals Skeletal Engraftment Sites of Transplanted Bone Marrow Cells

by Philipp Mayer-Kuckuk, Mikhail Doubrovin, Luc Bidaut, Tulin Budak-Alpdogan, Shangde Cai, Vanessa Hubbard, Onder Alpdogan, Marcel Van Den Brink, Joseph R. Bertino, Ronald G. Blasberg, Debabrata Banerjee, Juri Gelovani
Published 2006-01-01

Efficient generation of multipotent mesenchymal stem cells from umbilical cord blood in stroma-free liquid culture.

by Rowayda Peters, Monika J Wolf, Maries van den Broek, Mario Nuvolone, Stefanie Dannenmann, Bruno Stieger, Reto Rapold, Daniel Konrad, Arnold Rubin, Joseph R Bertino, Adriano Aguzzi, Mathias Heikenwalder, Alexander K Knuth
Published 2010-01-01

Functional annotation of rare gene aberration drivers of pancreatic cancer

by Yiu Huen Tsang, Turgut Dogruluk, Philip M. Tedeschi, Joanna Wardwell-Ozgo, Hengyu Lu, Maribel Espitia, Nikitha Nair, Rosalba Minelli, Zechen Chong, Fengju Chen, Qing Edward Chang, Jennifer B. Dennison, Armel Dogruluk, Min Li, Haoqiang Ying, Joseph R. Bertino, Marie-Claude Gingras, Michael Ittmann, John Kerrigan, Ken Chen, Chad J. Creighton, Karina Eterovic, Gordon B. Mills, Kenneth L. Scott
Published 2016-01-01

Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration

by Mark N. Stein, Jyoti Malhotra, Rohinton S. Tarapore, Usha Malhotra, Ann W. Silk, Nancy Chan, Lorna Rodriguez, Joseph Aisner, Robert D. Aiken, Tina Mayer, Bruce G. Haffty, Jenna H. Newman, Salvatore M. Aspromonte, Praveen K. Bommareddy, Ricardo Estupinian, Charles B. Chesson, Evita T. Sadimin, Shengguo Li, Daniel J. Medina, Tracie Saunders, Melissa Frankel, Aparna Kareddula, Sherrie Damare, Elayne Wesolowsky, Christian Gabel, Wafik S. El-Deiry, Varun V. Prabhu, Joshua E. Allen, Martin Stogniew, Wolfgang Oster, Joseph R. Bertino, Steven K. Libutti, Janice M. Mehnert, Andrew Zloza
Published 2019-05-01